Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Mar;17(3):374-9.
doi: 10.1111/j.1365-3156.2011.02933.x. Epub 2011 Dec 5.

Increasing access to the MDR-TB surveillance programme through a collaborative model in western Kenya

Affiliations
Free PMC article

Increasing access to the MDR-TB surveillance programme through a collaborative model in western Kenya

Paul H Park et al. Trop Med Int Health. 2012 Mar.
Free PMC article

Abstract

Objective: Kenya, like many resource-constrained countries, has a single mycobacterial laboratory, centrally located in Nairobi, with capacity for drug-susceptibility testing (DST) - the gold standard in diagnosing drug-resistant tuberculosis. We describe and evaluate a novel operational design that attempts to overcome diagnostic delivery barriers.

Methods: Review of the public DST programme identified several barriers limiting access: lack of programme awareness amongst physicians, limited supplies, unreliable transport and no specimen tracking methods. Staff visited 19 clinic sites in western Kenya and trained healthcare providers in regard to the novel diagnostics model. Provincial laboratory registries were reviewed to assess utilization of DST services prior to and after programme modification.

Results: Onsite training consisted of the inclusion criteria for re-treatment patients - the high-priority group for DST. Additionally, infrastructural support established a stable supply chain. An existing transport system was adapted to deliver sputum specimens. Task shifting created an accession and tracking system of specimens. During the 24 months post-implementation, the number of re-treatment specimens from the catchment area increased from 9.1 to 23.5 specimens per month. In comparing annual data pre- and post-implementation, the proportion of re-treatment cases receiving DST increased from 24.7% (n = 403) to 32.5% (n = 574) (P < 0.001), and the number of multidrug-resistant (MDR) TB cases increased from 5 to 10 cases.

Conclusion: The delivery model significantly increased the proportion of re-treatment cases receiving DST. Barriers to accessing the national MDR-TB surveillance programme can be overcome through an operational model based on pragmatic use of existing services from multiple partners.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Algorithm for DST/culture specimen collection, accession and electronic results tracking as implemented at 19 clinics in the catchment area of the MRL in western, Kenya.

References

    1. Boehme CC, Nabeta P, Hillemann D, et al. Rapid molecular detection of tuberculosis and rifampin resistance. The New England Journal of Medicine. 2010;363:1005–1015. - PMC - PubMed
    1. Boehme CC, Nicol MP, Nabeta P, et al. Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study. Lancet. 2011;377:1495–1505. - PMC - PubMed
    1. Espinal MA, Laserson K, Camacho M, et al. Determinants of drug-resistant tuberculosis: analysis of 11 countries. The International Journal of Tuberculosis and Lung Disease: The Official Journal of The International Union Against Tuberculosis and Lung Disease. 2001;5:887–893. - PubMed
    1. Farmer P, Bayona J, Becerra M, et al. The dilemma of MDR-TB in the global era. The International Journal of Tuberculosis and Lung Disease. 1998;2:869–876. - PubMed
    1. Faustini A, Hall AJ, Perucci CA. Risk factors for multidrug resistant tuberculosis in Europe: a systematic review. Thorax. 2006;61:158–163. - PMC - PubMed

Publication types

MeSH terms

Substances

Grants and funding